CXCR4, a therapeutic target in rare immunodeficiencies?

被引:4
作者
Bignon, Alexandre [1 ,2 ]
Biajoux, Vincent [1 ,2 ]
Bouchet-Delbos, Laurence [1 ,2 ]
Emilie, Dominique [1 ,2 ,3 ]
Lortholary, Olivier [4 ]
Balabanian, Karl [1 ,2 ]
机构
[1] Univ Paris 11, Lab Cytokines Chimiokines & Immunopathol, UMR S996, F-92140 Clamart, France
[2] INSERM, F-92140 Clamart, France
[3] AP HP, F-92140 Clamart, France
[4] Univ Paris 05, Hop Necker Enfants Malad, Serv Malad Infect & Trop, F-75743 Paris, France
来源
M S-MEDECINE SCIENCES | 2011年 / 27卷 / 04期
关键词
IDIOPATHIC CD4+ LYMPHOCYTOPENIA; WHIM SYNDROME PATIENTS; PROGENITOR CELLS; T-LYMPHOCYTES; RECEPTOR; DESENSITIZATION; INFECTION; DISEASE; UPDATE; CXCL12;
D O I
10.1051/medsci/2011274015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CXCR4, a therapeutic target in rare immunodeficiencies? Currently, more than 200 primary immunodeficiency diseases have been discovered. In most cases, genetic defects affect the expression or the function of proteins involved in immune development and homeostasis. Some orphan immuno-hematological disorders are characterized by an abnormal leukocyte trafficking, a notion predictive of an anomaly of the chemokine/chemokine receptor system. In this review, we focus on recent advances in the characterization of dysfunctions of the CXCL12 (SDF-1)/CXCR4 signaling axis in two rare human immunodeficiencies, one associated with a loss of CXCR4 function, the Idiopathic CDC(+) 1-cell Lymphocytopenia, and the other with a gain of CXCR4 function, the WHIM syndrome.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 27 条
[1]   WHIM4 syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 [J].
Balabanian, K ;
Lagane, B ;
Pablos, JL ;
Laurent, L ;
Planchenault, T ;
Verola, O ;
Lebbe, C ;
Kerob, D ;
Dupuy, A ;
Hermine, O ;
Nicolas, JF ;
Latger-Cannard, W ;
Bensoussan, D ;
Bordigoni, P ;
Baleux, F ;
Le Deist, F ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Bachelerie, F .
BLOOD, 2005, 105 (06) :2449-2457
[2]   The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J].
Balabanian, K ;
Lagane, B ;
Infantino, S ;
Chow, KYC ;
Harriague, J ;
Moepps, B ;
Arenzana-Seisdedos, F ;
Thelen, M ;
Bachelerie, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) :35760-35766
[3]   Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling [J].
Balabanian, Karl ;
Levoye, Angelique ;
Klemm, Lysiane ;
Lagane, Bernard ;
Hermine, Olivier ;
Harriague, Julie ;
Baleux, Francoise ;
Arenzana-Seisdedos, Fernando ;
Bachelerie, Francoise .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (03) :1074-1084
[4]   Orchestrating the orchestrators: chemokines in control of T cell traffic [J].
Bromley, Shannon K. ;
Mempel, Thorsten R. ;
Luster, Andrew D. .
NATURE IMMUNOLOGY, 2008, 9 (09) :970-980
[5]   Regulation of CXCR4 signaling [J].
Busillo, John M. ;
Benovic, Jeffrey L. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (04) :952-963
[6]   Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling [J].
Busillo, John M. ;
Armando, Sylvain ;
Sengupta, Rajarshi ;
Meucci, Olimpia ;
Bouvier, Michel ;
Benovic, Jeffrey L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (10) :7805-7817
[7]   Human hematopoiesis:: from CD34 cells to T lymphocytes [J].
Cavazzana-Calvo, Marina ;
Six, Emmanuelle ;
Andre-Schmutz, Isabelle ;
Coulombel, Laure .
M S-MEDECINE SCIENCES, 2007, 23 (02) :151-159
[8]   Multiple talents of the chemokine receptor-CXCR4 [J].
Desjardins, Sonia F. ;
Berchiche, Yamina A. ;
Haddad, Elie ;
Heveker, Nikolaus .
M S-MEDECINE SCIENCES, 2007, 23 (11) :980-984
[9]   Two cases of disseminated Mycobacterium avium infection associated with a new immunodeficiency syndrome related to CXCR4 dysfunctions [J].
Doncker, A-V. ;
Balabanian, K. ;
Bellanne-Chantelot, C. ;
de Guibert, S. ;
Revest, M. ;
Bachelerie, F. ;
Lamy, T. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (02) :135-139
[10]  
Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO